Galectin-1
3 papers1 finding
- Humans1
- Animals2
Associations
1Progression from mild cognitive impairment to AD dementia
upin humans1
1 study
Progression from mild cognitive impairment to AD dementia
upin humans1
Galectin-1 raises the risk of progression from mild cognitive impairment to AD dementia in humans.
“raised Gal‐1 levels in cerebrospinal fluid were a significant risk factor for the progression from mild cognitive impairment to AD dementia”
Humansin AD patients since prodromal stages
Galectin‐1 as a therapeutic strategy and a biomarker for Alzheimer's disease
AAIC 2025 abstractDec 23, 2025
Latest
2 in 12 monthsbioRxiv
Whole-Blood Transcriptomics Highlights Galectin-1 in Systolic Blood Pressure
Preprint: cohort study of 419 peopleBiomarkers
AAIC 2025 Abstract
Galectin‐1 as a therapeutic strategy and a biomarker for Alzheimer's disease
Experiments in miceAlzheimer's disease
International Journal of Molecular Sciences
Sweet Aging: Glycocalyx and Galectins in CNS Aging and Neurodegenerative Disorders
ReviewMechanisms
GeroScience
Blood-based biomarkers for early frailty are sex-specific: validation of a combined in silico prediction and data-driven approach
Cross-sectional study in peopleBiomarkers
Brain Research
Galectin-1 as a marker for microglia activation in the aging brain
Experiments in animalsMechanisms
CNS Neuroscience & Therapeutics
Galectin-1 ameliorates perioperative neurocognitive disorders in aged mice
Experiments in animalsInterventions
BMC Musculoskeletal Disorders
Age-related trabecular bone loss is associated with a decline in serum Galectin-1 level
Study in peopleBiomarkers
Microbiome
The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut
Experiments in animalsInterventions